When did Noxopharm become a publicly-listed company?
The Company listed on the Australian Securities Exchange in August 2016.
Who manages the Share Register (Transfer Agent)?
Automic Group Registry Services is Noxopharm Limited’s share registry and administers all matters relating to shares directly registered with the company. To login and access your shareholding please visit https://www.automicgroup.com.au/
How can I buy and sell company shares?
All company shares currently are traded on the ASX and can be bought or sold through a licensed stockbroker. The process of buying or selling shares is explained on the ASX website, please go to https://www.asx.com.au/products/shares/buying-selling-shares.htm
How can I obtain an Annual Report?
All annual reports are available on our website through this link
How can I follow the Company’s share price activity?
Current share prices are available on the ASX website www.asx.com.au and can be searched using the Company’s ASX ticker symbol: NOX
Does Noxopharm have any independent research coverage?
Yes, research coverage can be found in the Investors sections
What is the ASX ticker code?
The ASX ticker code for the Company is ASX: NOX.
Where do I find information about my shareholding?
The share register is managed by Automic Registry Services. The registry provides a number of services which can be accessed online. https://www.automicgroup.com.au/
When accessing some information online you may be required to enter your Security Reference Number (SRN) or Holder Identification Number (HIN) as shown on your Issuer Sponsored/CHESS statements and other personal details such as your postcode. Please visit the Glossary for more information.
Where can I find the latest financial information?
The latest financial reports can be found Noxopharm Financial reports
What is the Company’s financial year end?
The Company’s end of financial year is the 30th of June.
When will the AGM be held?
An Australian listed company is required to hold its annual general meeting within five months of its financial year end. Accordingly shareholders will be notified in the months of September or October, approximately 28 days in advance of when and where the AGM will be held. Typically, Noxopharm holds its AGM in mid-late November each year.
Who are the auditors?
The Company’s auditors are William Buck Audit Pty Ltd, L 20, 181 William St, Melbourne. VIC 3000
Where can I find the Corporate Governance Policy?
Our Corporate Governance policy can be found here: Noxopharm Corporate Governance Policy. This includes our Board Charter, Code of Conduct, Diversity Policy, Continuous Disclosure Policy, Shareholder Communication Policy, Risk Management Policy and our Securities Trading Policy.
Please visit: https://www.noxopharm.com/site/about-us/privacy-policy
What is the dividend policy?
The Company does not currently have a dividend policy in place. It is the Company’s intention to fully commercialise its drug candidates through a number of potential avenues, and to reinvest any future profits in order to grow the business. The Board reviews its growth strategy and potential commercial opportunities at regular meetings and assesses them against the Company’s working capital requirements and growth opportunities.
How can I request additional information?
Please email firstname.lastname@example.org requesting additional information
What is the Company’s mailing address?
Box 824, Turramurra. NSW 2074 NSW Australia
Who is the Company Secretary?
The Company Secretary is David Franks
T: +61 2 9299 9690 E: David.Franks@automicgroup.com.au